Living Homeopathy International Ltd（LHI）美股招股说明书 F-1 （2025-11-20修订版）（英文版）（189页）.pdf

《Living Homeopathy International Ltd（LHI）美股招股说明书 F-1 （2025-11-20修订版）（英文版）（189页）.pdf》由会员分享，可在线阅读，更多相关《Living Homeopathy International Ltd（LHI）美股招股说明书 F-1 （2025-11-20修订版）（英文版）（189页）.pdf（189页珍藏版）》请在三个皮匠报告上搜索。

1、F-1/A 1 ea0266385-f1a3_living.htm AMENDMENT NO.3 TO FORM F-1As filed with the Securities and Exchange Commission on November 19,2025Registration No.333-287532 UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549 AMENDMENT NO.3TOFORM F-1 REGISTRATION STATEMENTUNDERTHE SECURITIES ACT OF

2、 1933 Living Homeopathy International Ltd.(Exact name of registrant as specified in its charter)Cayman Islands 8099 Not Applicable(State or other jurisdiction ofincorporation or organization)(Primary Standard IndustrialClassification Code Number)(I.R.S.EmployerIdentification Number)4/F,Union Park Ce

3、ntre771-775 Nathan Road,Prince EdwardKowloon,Hong Kong+852 2625 4619(Address,including zip code,and telephone number,including area code,of registrants principal executive offices)Cogency Global Inc.122 East 42nd Street,18th FloorNew York,NY 10168(212)947-7200 (Name,address,including zip code,and te

4、lephone number,including area code,of agent for service)With a Copy to:Arila Er Zhou,Esq.Anna Jinhua Wang,Esq.Joy Zhuoyao Hui,Esq.Robinson&Cole LLPChrysler East Building666 Third Avenue,20th floorNew York,NY 10017Tel:(212)451-2908 Henry Yin,Esq.Benjamin Yao,Esq.Loeb&Loeb LLP2206-19 Jardine House1 Co

5、nnaught PlaceCentral,Hong Kong SARTel:852-3923-1111 Mitchell S.Nussbaum,Esq.Alex Weniger-Araujo,Esq.Loeb&Loeb LLP345 Park AvenueNew York,New York 10154Tel:(212)407-4000 Approximate date of commencement of proposed sale to the public:Promptly after the effective date of this registrationstatement.If

6、any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 underthe Securities Act of 1933 check the following box:If this Form is filed to register additional securities for an offering pursuant to Rule 462(b)under the Securities Act,